Advertisement
Canada markets open in 9 hours 18 minutes

  • S&P/TSX

    24,001.55
    -32.44 (-0.13%)
     

  • S&P 500

    5,709.54
    +0.79 (+0.01%)
     

  • DOW

    42,196.52
    +39.55 (+0.09%)
     

  • CAD/USD

    0.7396
    -0.0011 (-0.15%)
     

  • CRUDE OIL

    71.00
    +0.90 (+1.28%)
     

  • Bitcoin CAD

    82,995.30
    -346.88 (-0.42%)
     

  • XRP CAD

    0.73
    -0.08 (-10.31%)
     

  • GOLD FUTURES

    2,675.70
    +6.00 (+0.22%)
     

  • RUSSELL 2000

    2,195.00
    -2.03 (-0.09%)
     

  • 10-Yr Bond

    3.7850
    +0.0420 (+1.12%)
     

  • NASDAQ futures

    19,950.00
    -59.75 (-0.30%)
     

  • VOLATILITY

    18.90
    -0.36 (-1.87%)
     

  • FTSE

    8,290.86
    +14.21 (+0.17%)
     

  • NIKKEI 225

    38,576.21
    +767.45 (+2.03%)
     

  • CAD/EUR

    0.6701
    0.0000 (0.00%)
     

Here's What Key Metrics Tell Us About Walgreens (WBA) Q3 Earnings

Zacks Equity Research
·2 min read

Walgreens Boots Alliance (WBA) reported $36.35 billion in revenue for the quarter ended May 2024, representing a year-over-year increase of 2.6%. EPS of $0.63 for the same period compares to $1.00 a year ago.

The reported revenue represents a surprise of +1.07% over the Zacks Consensus Estimate of $35.96 billion. With the consensus EPS estimate being $0.67, the EPS surprise was -5.97%.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how Walgreens performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

  • Revenues- U.S. Retail Pharmacy: $28.50 billion compared to the $27.89 billion average estimate based on five analysts. The reported number represents a change of +2.3% year over year.

  • Revenues- U.S. Healthcare: $2.13 billion compared to the $2.12 billion average estimate based on five analysts. The reported number represents a change of +7.6% year over year.

  • Revenues- International: $5.73 billion versus $5.74 billion estimated by five analysts on average. Compared to the year-ago quarter, this number represents a +2.8% change.

  • Adjusted operating income (loss)- U.S. Retail Pharmacy: $501 million versus $620.19 million estimated by four analysts on average.

  • Adjusted operating income (loss)- Corporate and Other: -$42 million versus -$57.38 million estimated by four analysts on average.

  • Adjusted operating income (loss)- U.S. Healthcare: -$22 million versus -$48.35 million estimated by four analysts on average.

  • Adjusted operating income (loss)- International: $175 million versus the four-analyst average estimate of $190.99 million.

View all Key Company Metrics for Walgreens here>>>

Shares of Walgreens have returned +5.2% over the past month versus the Zacks S&P 500 composite's +3.4% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Walgreens Boots Alliance, Inc. (WBA) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research